window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 1, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Research & Development

  • Central Nervous System,Neurosciences,Pharmaceuticals and therapeutics,Research & Development

    Porosome reconstitution therapy reverses Alzheimer’s pathology in human brain organoids

    Porosome Therapeutics has reported preclinical results showing that restoring porosome [...]

    November 18, 2025
  • Biotech,Clinical Development,Clinical Trials,Neurosciences,Research & Development

    Scottish Brain Sciences opens new Alzheimer’s clinical research centre at ONE BioHub

    Scottish Brain Sciences (SBS), a clinical research organisation focused on [...]

    November 17, 2025
  • Artificial Intelligence,Biologics & Biosimilars,Biotech,Cell & Gene Therapy,Chronic diseases,Drug Development,Genomics and sequencing,Precision medicine,Research & Development

    Mursla Bio partners with global pharma to advance biomarker-guided precision medicine in MASH

    Mursla Bio has announced a collaboration with a leading global [...]

    November 13, 2025
  • Neurosciences,Rare Diseases,Research & Development

    Successful treatment for ALS could deliver billions in global value

    New research commissioned by Challenge Works and conducted by the [...]

    November 13, 2025
  • Biologics & Biosimilars,Biotech,Clinical Development,Oncology,Research & Development

    SOTIO reports positive non-human primate data for SOT106 ADC in sarcoma

    SOTIO Biotech has reported positive preclinical results for SOT106, its [...]

    November 12, 2025
  • Biotech,Central Nervous System,Clinical Development,Neurosciences,Partnerships & Funding,Research & Development

    Modulight Biotherapeutics raises $12 million seed funding for optogenetic therapy development

    Modulight Biotherapeutics has raised $12.2 million in a Seed funding [...]

    November 13, 2025
  • Artificial Intelligence,Biotech,Research & Development,Technology and platforms

    Shift Bioscience refines metric calibration to improve AI virtual cell performance

    Shift Bioscience has published new research presenting an improved framework [...]

    November 12, 2025
  • Biologics & Biosimilars,Biotech,Drug Development,Events and Conferences,Research & Development,Technology and platforms

    Abselion launches His-tag protein quantification kit and sensors for Amperia at PEGS Europe 2025

    Abselion has expanded its Amperia assay portfolio with the launch [...]

    November 11, 2025
  • Biotech,Clinical Development,Drug Development,Events and Conferences,Neurosciences,Pharmaceuticals and therapeutics,Research & Development

    Medicinova wins contract research and development innovation award at biotech breakthrough awards 2025

    MediciNova has been recognised with the Contract Research and Development [...]

    November 10, 2025
  • Clinical Development,Oncology,Research & Development

    Williams Cancer Institute reports success with combined ablation and immunotherapy

    Study shows tumour regression with no treatment-related toxicity in head [...]

    November 10, 2025
Previous131415Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Cereno Scientific reports long-term safety data from CS1 pulmonary arterial hypertension program
    Categories: Cardiovascular diseases, Clinical Trials, Rare Diseases, Regulatory Affairs, Research & Development
  • City St George’s and Paradigm Biopharmaceuticals study osteoarthritis pain drug mechanism
    Categories: Clinical Trials, Neurosciences, Partnerships & Funding, Research & Development
  • BIOGRUND and Seprify launch plant-based tablet coating to replace titanium dioxide
    Categories: Ingredients, Manufacturing, Packaging, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top